학술논문

1103P Nivolumab (NIVO) plus relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma: 2-year subgroup analyses from RELATIVITY-047
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S664-S665
Subject
Language
ISSN
0923-7534